HemaSphere Podcast
av HemaSphere Journal
Nyeste episode
CAR T From Within - Vilcot, Brugère, Fuentealba, Houot
CAR T From Within - Vilcot, Brugère, Fuentealba, Houot
Om denne podkasten
HemaSphere is the official online, open access journal of the European Hematology Association (EHA). HemaSphere publishes exciting basic, translational, and clinical research in hematology. We are pleased to introduce our new podcast series where our host and guest speakers exchange ideas about select HemaSphere publications. Spend some time with us and enjoy casual and insightful discussions about hematology research. Listen to the stories behind the papers. HemaSphere is always accessible; our full range of open access publications is available at www.hemaspherejournal.com.
Episoder
De 20 nyeste av 30 episoder
- CAR T From Within - Vilcot, Brugère, Fuentealba, Houot · 40 min · Sesong 4 Episode 6Could making CAR T cells directly inside the patient change how treatment is delivered? Scientific Editor Dr Charles De Bock joins Prof Roch Houot, Dr Jaime Fuentealba, François…
- Why More Mitochondrial DNA Mutations Can Mean a Better Outcome - Dr Ilaria Pagani · 41 min · Sesong 4 Episode 5This episode explores how chronic myeloid leukemia has been transformed by imatinib and other TKIs, while also showing why major clinical challenges remain for the patients who…
- Why Inflammatory Signaling Holds the Key to Durable MDS Therapies - Dr Manja Wobus, Dr Katja Sockel · 38 min · Sesong 4 Episode 4In this episode, host Dr Charles de Bock delves into groundbreaking preclinical research exploring the potential of tasquinimod to restore blood cell production and modify the…
- p53 in Cancer: Dual Threat - Dr Isabelle Plo, Dr Barbara Monte-Mór · 37 min · Sesong 4 Episode 3Discover the latest insights into the multifaceted role of p53 in normal hematopoiesis and its critical involvement in myeloproliferative neoplasms (MPNs). This episode features…
- Blinatumomab in De Novo AYA ALL - Dr Matthew Greenwood · 47 min · Sesong 4 Episode 2In this episode, host HemaSphere Scientific Editor Dr Charley de Bock speaks with Associate Professor Dr Matthew Greenwood about the SUBLIME (ALL09) trial, which explores…
- Inequalities in sickle cell therapies - Dr Stephen Hibbs, Dr Paul Telfer, Mary-Shaniqua - Patient Advocate · 55 min · Sesong 4 Episode 1In this extended episode of the HemaSphere podcast, based on a must-read Perspective "Can health inequalities in sickle cell disease be addressed through novel therapies?", our…
- Defining Lineage in Ambiguous Leukemia: A Transcriptomic View - Dr. Anikó Sijs-Szabó & Roger Mulet Lázaro, PhD · 36 min · Sesong 3 Episode 8Dr. Anikó Sijs-Szabó & Roger Mulet Lázaro, PhD, join Dr. Charles de Bock to unpack the challenges of diagnosing and treating acute leukemias of ambiguous lineage (ALAL). Discover…
- EHA/EBMT Survey on Grading and Management of ICAHT - Dr Kai Rejeski · 41 min · Sesong 3 Episode 7Join our host HemaSphere Scientific Editor Dr Charles de Bock as he chats with Dr Kai Rejeski, first author of this 2025 HemaSphere Top Cited –Clinical Award-winning paper. The…
- Tackling NUP98 Rearranged AML in Pediatric Oncology - Prof Michel Zwaan, Prof Olaf Heidenreich · 41 min · Sesong 3 Episode 6Host Dr Charles de Bock speaks with Prof Michel Zwaan and Prof Olaf Heidenreich, co-authors from the 2025 HemaSphere Award - Top Cited: Biology paper, "The MLL-Menin Interaction…
- Part 2 - Metabolism in hematology - Ep 3.4 · 29 min · Sesong 3 Episode 5In this second part of a 2-part episode, Dr Charles De Bock engages with Prof Dr Petya Apostolova and Dr Jörg Büscher to explore the intricate relationship between metabolism and…
- Part 1 - Metabolism in hematology - Ep 3.4 · 30 min · Sesong 3 Episode 4In this 2-part episode of the HemaSphere podcast, host Dr Charles de Bock and guests Dr Jörg Büscher and Prof Dr Petya Apostolova discuss the critical role of metabolism in…
- Machine learning for AML-MRD - Ep 3.3 · 29 min · Sesong 3 Episode 3In this episode of the HemaSphere podcast, host Charles de Bock and guest Tim Mocking, PhD, discuss the role of machine learning in the assessment of measurable residual disease…
- 2 of 2: Navigating Neutropenia: New Guidelines Explained - Ep 3.2 · 28 min · Sesong 3 Episode 2In this episode of the HemaSphere podcast, host Dr Charles De Bock discusses the newly published Guidelines on the treatment of neutropenias with co-authors Dr. Francesca…
- Single‐cell DNA and surface protein - Ep 3.1 · 34 min · Sesong 3 Episode 1In this episode of the HemaSphere podcast, host Charles De Bock engages with HemaSphere Editor in Chief Professor Jan Cools, Professor Heidi Segers, and Doctor Margo Aertgeerts…
- Two distinct fetal-type signatures characterize JMML - Ep 2.8 · 37 min · Sesong 2 Episode 8In this episode of the HemaSphere podcast, host Charles de Bock engages with Professor Hélène Cavé and Dr. Marion Strullu to discuss their recent study on juvenile myelomonocytic…
- Revolutionizing Pediatric Cancer Research with PDXs - Ep 2.7 · 36 min · Sesong 2 Episode 7In this episode of the HemaSphere podcast, host Dr Charles de Bock discusses the critical role of mouse models in understanding leukemogenesis and hematopoiesis with Prof Richard…
- High 5hmC predicts worse OS - Ep 2.6 · 25 min · Sesong 2 Episode 6In this episode of the HemaSphere podcast, host Charles de Bock discusses the latest research on myelodysplastic syndrome (MDS) with Dr Francesca Tiso and Dr Florentien in 't…
- Informed consent is almost impossible - Ep 2.5 · 39 min · Sesong 2 Episode 5This podcast episode delves into the complexities of informed consent in healthcare, particularly in the context of hematology. The discussion with host Dr Charles de Bock…
- Best of Pediatric Hematology from EHA2024 - Ep 2.4 · 42 min · Sesong 2 Episode 4In the latest episode, Dr Charles de Bock talks with Prof H. Josef Vormoor and Dr Maria Ester Bernardo, Chair and Co-Chair of EHA’s Pediatric Hematology Specialized Working…
- NOTCH1 fusions in T‐LBL - Ep 2.3 · 24 min · Sesong 2 Episode 3Authors of this recent HemaSphere published paper discovered a high-risk subgroup of pediatric T-LBL, defined by NOTCH1 gene fusions. This finding will have an important impact…
